Schizophrenia Trial, Recruiting NCT06278532 Sponsor: Lithuanian University of Health Sciences Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06278532
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 65 years old
  • People who have been diagnosed with schizophrenia, schizoaffective disorder, or schizophrenia-like psychotic disorder (classified as F20, F25, or F21 under the international ICD-10 diagnostic system)
  • People who have signed a form giving their agreement to take part in the trial

Who may not be able to join:

  • People who are younger than 18 or older than 65 years old
  • People who have not signed the agreement form to take part
  • People who are considered legally incapacitated (meaning a court or legal authority has determined they cannot make certain decisions for themselves — confirm with trial site)
  • People who have also been diagnosed with an intellectual disability (classified as F70–F79 under ICD-10), either as a separate or main diagnosis
  • People who have also been diagnosed with a mental or behavioural disorder caused by the use of substances such as alcohol or drugs (classified as F10–F19 under ICD-10), either as a separate or main diagnosis
  • People who have also been diagnosed with an organic brain disorder — meaning a mental condition caused by a physical condition affecting the brain (classified as F00–F09 under ICD-10), either as a separate or main diagnosis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Virginija Adomaitienė, Prof., Lithuanian University of Health Sciences

Phone: +37066240919

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lithuanian University of Health Sciences
Registry
ClinicalTrials.gov
Start date
11 December 2023
Est. completion
11 December 2026

Where this trial is recruiting

🇱🇹 Lithuania

Primary endpoints

Validated Lithuanian version of the Brief Negative Symptoms Scale.; Validated Lithuanian version of the Calgary Depression Scale for Schizophrenia.; Validated Lithuanian version of the Schizophrenia Cognition Rating Scale.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov